Arama Sonu&ccedil;lar&#305; Antibodies. - Daralt&#305;lm&#305;&#351;: Oncology. SirsiDynix Enterprise https://katalog.hacettepe.edu.tr/client/tr_TR/default_tr/default_tr/qu$003dAntibodies.$0026qf$003dSUBJECT$002509Konu$002509Oncology.$002509Oncology.$0026ps$003d300?dt=list 2024-11-22T19:53:04Z Bispecific Antibodies ent://SD_ILS/0/SD_ILS:194528 2024-11-22T19:53:04Z 2024-11-22T19:53:04Z Yazar&#160;Kontermann, Roland E. editor.&#160;SpringerLink (Online service)<br/>Yer Numaras&#305;&#160;ONLINE<br/>Elektronik Eri&#351;im&#160;<a href="http://dx.doi.org/10.1007/978-3-642-20910-9">http://dx.doi.org/10.1007/978-3-642-20910-9</a><br/>Format:&#160;Elektrnik Kaynak<br/>Durum&#160;&Ccedil;evrimi&ccedil;i K&uuml;t&uuml;phane~1<br/> Therapeutic Antibodies ent://SD_ILS/0/SD_ILS:186792 2024-11-22T19:53:04Z 2024-11-22T19:53:04Z Yazar&#160;Chernajovsky, Yuti. editor.&#160;Nissim, Ahuva. editor.&#160;SpringerLink (Online service)<br/>Yer Numaras&#305;&#160;ONLINE<br/>Elektronik Eri&#351;im&#160;<a href="http://dx.doi.org/10.1007/978-3-540-73259-4">http://dx.doi.org/10.1007/978-3-540-73259-4</a><br/>Format:&#160;Elektrnik Kaynak<br/>Durum&#160;&Ccedil;evrimi&ccedil;i K&uuml;t&uuml;phane~1<br/> Resistance of Targeted Therapies Excluding Antibodies for Lymphomas ent://SD_ILS/0/SD_ILS:401396 2024-11-22T19:53:04Z 2024-11-22T19:53:04Z Yazar&#160;Ferreri, Andr&eacute;s J. M. editor.&#160;SpringerLink (Online service)<br/>Yer Numaras&#305;&#160;ONLINE<br/>Elektronik Eri&#351;im&#160;<a href="https://doi.org/10.1007/978-3-319-75184-9">https://doi.org/10.1007/978-3-319-75184-9</a><br/>Format:&#160;Elektrnik Kaynak<br/>Durum&#160;&Ccedil;evrimi&ccedil;i K&uuml;t&uuml;phane~1<br/> Resistance to Immunotherapeutic Antibodies in Cancer Strategies to Overcome Resistance ent://SD_ILS/0/SD_ILS:332319 2024-11-22T19:53:04Z 2024-11-22T19:53:04Z Yazar&#160;Bonavida, Benjamin. editor.&#160;SpringerLink (Online service)<br/>Yer Numaras&#305;&#160;ONLINE(332319.1)<br/>Elektronik Eri&#351;im&#160;<a href="http://dx.doi.org/10.1007/978-1-4614-7654-2">http://dx.doi.org/10.1007/978-1-4614-7654-2</a><br/>Format:&#160;Elektrnik Kaynak<br/>Durum&#160;&Ccedil;evrimi&ccedil;i K&uuml;t&uuml;phane~1<br/> Antibody-Drug Conjugates and Immunotoxins From Pre-Clinical Development to Therapeutic Applications ent://SD_ILS/0/SD_ILS:331777 2024-11-22T19:53:04Z 2024-11-22T19:53:04Z Yazar&#160;Phillips, Gail Lewis. editor.&#160;SpringerLink (Online service)<br/>Yer Numaras&#305;&#160;ONLINE(331777.1)<br/>Elektronik Eri&#351;im&#160;<a href="http://dx.doi.org/10.1007/978-1-4614-5456-4">http://dx.doi.org/10.1007/978-1-4614-5456-4</a><br/>Format:&#160;Elektrnik Kaynak<br/>Durum&#160;&Ccedil;evrimi&ccedil;i K&uuml;t&uuml;phane~1<br/> Drugs for HER-2-positive Breast Cancer ent://SD_ILS/0/SD_ILS:176626 2024-11-22T19:53:04Z 2024-11-22T19:53:04Z Yazar&#160;Sibilia, Maria. editor.&#160;Zielinski, Christoph C. editor.&#160;Bartsch, Rupert. editor.&#160;Grunt, Thomas W. editor.&#160;SpringerLink (Online service)<br/>Yer Numaras&#305;&#160;ONLINE<br/>Elektronik Eri&#351;im&#160;<a href="http://dx.doi.org/10.1007/978-3-0346-0094-1">http://dx.doi.org/10.1007/978-3-0346-0094-1</a><br/>Format:&#160;Elektrnik Kaynak<br/>Durum&#160;&Ccedil;evrimi&ccedil;i K&uuml;t&uuml;phane~1<br/> Metastasis of Colorectal Cancer ent://SD_ILS/0/SD_ILS:205330 2024-11-22T19:53:04Z 2024-11-22T19:53:04Z Yazar&#160;Beauchemin, Nicole. editor.&#160;Huot, Jacques. editor.&#160;SpringerLink (Online service)<br/>Yer Numaras&#305;&#160;ONLINE<br/>Elektronik Eri&#351;im&#160;<a href="http://dx.doi.org/10.1007/978-90-481-8833-8">http://dx.doi.org/10.1007/978-90-481-8833-8</a><br/>Format:&#160;Elektrnik Kaynak<br/>Durum&#160;&Ccedil;evrimi&ccedil;i K&uuml;t&uuml;phane~1<br/>